Location History:
- Berkshire, GB (2019)
- Slough, GB (2014 - 2022)
Company Filing History:
2 out of 138 
1 out of 179 
1 out of 109 Years Active: 2014-2022
Title: Paul Edward Stephens: Innovator in Multimeric Fusion Proteins
Introduction
Paul Edward Stephens is a notable inventor based in Slough, GB. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of multimeric fusion proteins. With a total of 4 patents to his name, his work has implications for the treatment of various immune disorders.
Latest Patents
Among his latest patents, one notable invention is related to multimeric Fc proteins. This invention focuses on multimeric fusion proteins that bind to human Fc receptors. It also encompasses therapeutic compositions that include these proteins, aimed at treating immune disorders. Another significant patent involves single-chain Fc polypeptides, which comprise one or more immunoglobulin Fc domains. This invention highlights single-chain Fc polypeptides where at least one functional Fc domain is formed within the polypeptide chain.
Career Highlights
Throughout his career, Paul has worked with prominent companies in the biopharmaceutical sector, including UCB Biopharma Sprl and UCB Pharma, S.A. His expertise in the field has allowed him to contribute to innovative solutions in healthcare.
Collaborations
Paul has collaborated with several professionals in his field, including Shirley Jane Peters and Katharine Lacy Cain. These collaborations have further enriched his work and expanded the impact of his inventions.
Conclusion
Paul Edward Stephens is a distinguished inventor whose work in multimeric fusion proteins and polypeptides has the potential to advance therapeutic options for immune disorders. His contributions to the field are noteworthy and continue to influence biopharmaceutical innovations.